Pentostatin, Cyclophosphamide, and Rituximab in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia
Clinical trial NCT00541034 · COMPLETED
Trial details
- NCT number
- NCT00541034
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-05-01
- Primary completion
- 2016-01-01
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.